Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.

A 40-year-old Hispanic man presented for treatment of dermatitis on his elbows and knees that had been evident for 5 years (Figure 1). He also had scaling plaques ... was made of psoriasis and ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

Psoriasis is a chronic skin disease that manifests itself mainly with skin symptoms (dryness, itching, scaly skin, abnormal patches and plaques). It affects about 2% of the population and is mediated ...

Even though he suffers from psoriasis, Joel Thomas considers himself a lucky man. Psoriasis is a chronic skin disorder that affects over seven and a half million Americans. Many are not as lucky ...

Plaque psoriasis is the most common ... But treatment can help you feel better. You may need topical, oral, or systemic treatments. There are some things most everyone can do to help keep ...

When categorizing the severity of psoriasis, it’s generally defined by the total amount of skin surface area covered by plaques. Less than 3% is considered mild, 3-10% moderate, and anything ...

Injectable drugs such as methotrexate and biologics may help clear up plaques and reduce inflammation. Biologics often help when other treatments haven’t worked to treat psoriasis. They’re ...

Other options in therapy include topical corticosteroids ... the potential for developing chronic plaque-type psoriasis. Education about diagnosis and treatment of streptococcal infection with ...

For decades, treatment approaches for moderate to severe psoriasis were largely limited to topical creams, phototherapy and systemic medications 7. More recently, comprehensive research has ...

Plaque psoriasis is the most common type ... Treatments can be divided into topical treatments, light therapy (phototherapy or photodynamic therapy) and systemic (oral or injected) medications.